ARTEGRAFT AG730

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor,health profession report with the FDA on 2016-05-03 for ARTEGRAFT AG730 manufactured by Artegraft, Inc..

Event Text Entries

[44291973] Upon follow-up communications the doctor was able to verify the lot number of the implanted artegraft based on the patient's files. Artegraft, inc. Performed a review of the batch history records; upon release, the batch met all requirements including sterility results. Note: udi was not applicable at the time of product manufacture/release in 2010. The graft was not returned for evaluation as it remains implanted. It should be noted that aneurysms are listed in the current artegraft, inc. Instructions for use as a known potential adverse reaction. In addition, artegraft's current patient information guide instructs patients to request the dialysis caregiver to rotate needle access sites and to watch for any unusual complications, such as "ballooning" of the graft. A review of complaint files in the past 2 years was reviewed; no trend was identified for aneurysm. The complaint issue will continue to be monitored within artegraft, inc. Quality systems, quality assurance trending. Should additional information become available, a follow-up report will be submitted. Graft remains implanted.
Patient Sequence No: 1, Text Type: N, H10


[44291974] Artegraft, inc. Received an email communication from an authorized distributor, on behalf of the doctor, requesting information to be relayed back to the patient. The doctor had completed a fem-pop on the patient on (b)(6) 2010 utilizing an artegraft (collagen vascular graft); within a few years, aneurysms started to form in the artegraft so he has been watching the graft closely since then. The doctor finally replaced the graft in the last month [(b)(6) 2016] with ptfe. The doctor was "very surprised as this is the only artegraft he's had issues with after utilizing several thousand". The doctor wondered if artegraft, inc. Would be able to track the graft back to the lot number from the patient's implant date and be able to provide any feedback on the quality control of the graft that he could show to the patient showing the integrity of the graft. Upon follow up communications, the doctor clarified that the artegraft was not explanted when the new ptfe graft was implanted. He agreed to review the patient or files to attempt to identify the artegraft lot information.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2247686-2016-00005
MDR Report Key5628203
Report SourceDISTRIBUTOR,HEALTH PROFESSION
Date Received2016-05-03
Date of Report2016-04-07
Date of Event2016-02-09
Date Mfgr Received2016-04-07
Device Manufacturer Date2010-04-15
Date Added to Maude2016-05-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCYNTHIA SALTER
Manufacturer Street206 NORTH CENTER DRIVE
Manufacturer CityNORTH BRUNSWICK NJ 089024247
Manufacturer CountryUS
Manufacturer Postal089024247
Manufacturer Phone7324228333
Manufacturer G1ARTEGRAFT, INC
Manufacturer Street206 NORTH CENTER DRIVE
Manufacturer CityNORTH BRUNSWICK NJ 089024247
Manufacturer CountryUS
Manufacturer Postal Code089024247
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARTEGRAFT
Generic NameCOLLAGEN VASCULAR GRAFT
Product CodeLXA
Date Received2016-05-03
Model NumberAG730
Catalog NumberAG730
Lot Number10C031-011
Device Expiration Date2013-03-31
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerARTEGRAFT, INC.
Manufacturer Address206 NORTH CENTER DRIVE NORTH BRUNSWICK NJ 089024247 US 089024247


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-05-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.